Article10.1023/a:1006173019048

Soluble CD95 (Fas/APO-1) in Malignant Glioma: (No) Implications for CD95-based Immunotherapy?

Johannes Streffer,Monika Schuster,Frauke Zipp,Michael Weller-1998-12-01-Journal of Neuro-Oncology

11

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

GliomaFas receptorImmunotherapyCancer researchIn vivoMedicineBiologyImmunology

Chat

Click to start Chat